Loading...
XNYS
COR
Market cap65bUSD
Dec 04, Last price  
337.63USD
1D
0.69%
1Q
15.43%
Jan 2017
325.39%
Name

Amerisourcebergen Corp

Chart & Performance

D1W1MN
XNYS:COR chart
P/E
43.36
P/S
0.22
EPS
7.79
Div Yield, %
0.45%
Shrs. gr., 5y
-1.12%
Rev. gr., 5y
10.36%
Revenues
293.96b
+12.12%
54,577,321,00061,203,145,00066,074,312,00070,189,733,00071,759,990,00077,953,979,00080,217,558,00078,080,806,00087,959,167,000119,569,127,000135,961,803,000146,849,686,000153,143,826,000167,939,635,000179,589,121,000189,893,926,000213,988,843,000238,587,006,000262,173,411,000293,958,599,000
Net income
1.51b
-13.53%
319,199,000467,714,000469,167,000250,559,000503,397,000636,748,000706,624,0005,048,00018,841,00022,765,00034,706,00058,709,00074,855,00077,922,000855,365,000-3,408,716,0001,539,932,0001,698,820,0001,745,293,0001,509,120,000
CFO
3.48b
-10.91%
1,526,638,000807,265,0001,207,904,000737,069,000783,763,0001,108,624,0001,167,948,0001,305,449,000788,125,0001,463,153,0003,920,379,0003,178,497,0001,489,007,0001,411,388,0002,344,023,0002,207,040,0002,666,586,0002,703,088,0003,911,334,0003,484,685,000
Dividend
Aug 09, 20240.51 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
IPO date
May 28, 1996
Employees
480
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT